首页> 外国专利> Antilipaemic compsns. contg. polymerised acidic amino acids - for oral admin. and having no anticoagulant side effect

Antilipaemic compsns. contg. polymerised acidic amino acids - for oral admin. and having no anticoagulant side effect

机译:抗血脂药。续聚合的酸性氨基酸-口服而且没有抗凝副作用

摘要

Antilipaemic compsn. for oral administration comprises as active ingredient =1 poly(acidic amino acid) (I) of mol. wt. 10,000-100,000 or its pharmaceutically acceptable salts, and an adjuvant. (I) may be a homo- or copolymer, pref. of mol. wt. 30000-90000, and is formulated as a tablet or pill. (I) Reduced the blood level of total lipids, cholesterol, triglycerides, beta-lipoproteins etc. Unlike heparin and dextrian sulphate they have no anticoagulant side effect; are of low toxicity (LD50(p.o. rats) for polyglutamic acid is 6g/kg) and can safely be given for prolonged periods. Pref. (I) are homo- or copolymers of glutamic, aspartic and cysteic acids. Suitable granules comprise 200mg polyglutamic acid or its Na sa 290mg. lactose; 500mg maize starch and 10mg hydroxypropyl cellulose.
机译:抗血脂药。用于口服的药物包含> = 1的摩尔的聚(酸性氨基酸)(I)作为活性成分。重量10,000-100,000或其可药用盐和佐剂。 (I)可以是均聚物或共聚物。摩尔重量30000-90000,并制成片剂或药丸。 (I)降低血液中的总脂质,胆固醇,甘油三酸酯,β-脂蛋白等水平。与肝素和硫酸葡聚糖不同,它们没有抗凝副作用;具有低毒性(聚谷氨酸的半数致死剂量(LD50))为6g / kg,可以安全地长期服用。首选(I)是谷氨酸,天冬氨酸和半胱氨酸的均聚物或共聚物。合适的颗粒剂包括200mg聚谷氨酸或其钠盐; 290毫克乳糖; 500mg玉米淀粉和10mg羟丙基纤维素。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号